MarketCap
Facebook
X
TelegramStrongbridge Biopharma plc P/B Ratio 2011-2026 | SBBP
Annual P/B Ratio Strongbridge Biopharma plc
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 2.31 | 2.17 | 1.94 | -20.7 | 0.708 | 0.845 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.31 | -20.7 | -2.12 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B |  USA |
 |
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B |  France |
 |
Autolus Therapeutics plc
AUTL
|
1.81 | $ 1.38 | -1.08 % | $ 367 M |  Britain |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | France |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | USA |
 |
DBV Technologies S.A.
DBVT
|
16.7 | $ 20.52 | 0.79 % | $ 2.86 B | France |
 |
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.72 | 3.24 % | $ 8.95 B |  Australia |
 |
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | USA |
 |
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | USA |
 |
Aytu BioScience
AYTU
|
0.127 | $ 2.57 | -3.48 % | $ 16.1 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Forte Biosciences
FBRX
|
5.5 | $ 26.92 | 1.8 % | $ 349 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
4.76 | $ 6.22 | -3.12 % | $ 178 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | USA |
 |
Fulcrum Therapeutics
FULC
|
0.00154 | $ 7.72 | -1.4 % | $ 489 K | USA |
 |
Galectin Therapeutics
GALT
|
-1.41 | $ 2.24 | -12.55 % | $ 143 M | USA |
 |
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | USA |
 |
Gilead Sciences
GILD
|
3.11 | $ 138.79 | -0.96 % | $ 173 B | USA |
 |
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | Canada |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
0.0645 | $ 0.56 | 8.45 % | $ 521 K |  Israel |
 |
Genmab A/S
GMAB
|
8.26 | $ 27.26 | -1.77 % | $ 17.2 B |  Danmark |
 |
Gossamer Bio
GOSS
|
-0.875 | $ 0.32 | -7.03 % | $ 73.1 M | USA |
 |
Grifols, S.A.
GRFS
|
1.15 | $ 8.02 | -2.55 % | $ 6.83 B |  Spain |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
GT Biopharma
GTBP
|
0.382 | $ 0.41 | -7.26 % | $ 2.26 M | USA |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | Germany |
 |
BioNTech SE
BNTX
|
5.29 | $ 88.74 | -2.78 % | $ 27.2 B | Germany |
 |
Halozyme Therapeutics
HALO
|
198 | $ 63.49 | 0.64 % | $ 7.61 B | USA |
 |
Coherus BioSciences
CHRS
|
3.71 | $ 1.62 | -3.1 % | $ 190 M | USA |
 |
Akari Therapeutics, Plc
AKTX
|
285 | $ 3.32 | -6.21 % | $ 224 B | Britain |
 |
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
3.16 | - | 3.16 % | $ 1.9 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
51.7 | $ 318.56 | -3.57 % | $ 41.7 B | USA |
 |
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | USA |
 |
Harmony Biosciences Holdings
HRMY
|
1.85 | $ 27.62 | -0.34 % | $ 1.59 B | USA |
 |
Aileron Therapeutics
ALRN
|
0.702 | - | 10.36 % | $ 9.8 M | USA |
 |
AlloVir
ALVR
|
-0.258 | - | 4.14 % | $ 49.1 M | USA |
 |
iBio
IBIO
|
4.07 | $ 2.08 | 2.47 % | $ 21.8 M | USA |
 |
ImmuCell Corporation
ICCC
|
2.15 | $ 6.54 | -1.06 % | $ 59 M | USA |
 |
InflaRx N.V.
IFRX
|
1.41 | $ 0.99 | 4.91 % | $ 152 M | Germany |
 |
Burford Capital Limited
BUR
|
1.26 | $ 4.46 | -0.45 % | $ 729 M | Britain |
 |
Immutep Limited
IMMP
|
26.6 | $ 0.35 | -3.58 % | $ 1.08 B | Australia |